• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一氧化氮在依托泊苷(VP-16,213)的化学性质和抗癌活性中的作用。

Role of nitric oxide in the chemistry and anticancer activity of etoposide (VP-16,213).

机构信息

Laboratory of Toxicology & Pharmacology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, United States.

出版信息

Chem Res Toxicol. 2013 Mar 18;26(3):379-87. doi: 10.1021/tx300480q. Epub 2013 Feb 26.

DOI:10.1021/tx300480q
PMID:23402364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3697829/
Abstract

Originally identified as an innate cytotoxin, nitric oxide ((·)NO) formation in tumors can influence chemotherapy and exacerbate cancer progression. Here, we examined the hypothesis that (·)NO generation contributes to cancer cell drug resistance toward the widely used anticancer drug Etoposide (VP-16). The UV-vis spectrum of VP-16 was not changed by exposure of VP-16 to (·)NO in aqueous buffer. In contrast, reddish-orange compound(s) characteristic of o-quinone- and nitroso-VP-16 were readily generated in a hydrophobic medium (chloroform) in an oxygen-dependent manner. Similar products were also formed when the VP-16 radical, generated from VP-16 and horseradish peroxidase/H2O2, was exposed directly to (·)NO in chloroform in the presence of oxygen. Separation and spectral analysis of VP-16 reaction extracts by electron spin resonance and UV-vis indicated the generation of the phenoxy radical and the o-quinone of VP-16, as well as putative nitroxide, iminoxyl, and other nitrogen oxide intermediates. Nitric oxide products of VP-16 displayed significantly diminished topoisomerase II-dependent cleavage of DNA and cytotoxicity to human HL-60 leukemia cells. LPS-mediated induction of nitric oxide synthase in murine macrophages resulted in VP-16 resistance compared to Raw cells. Furthermore, (·)NO products derived from iNOS rapidly reacted with VP-16 leading to decreased DNA damage and cytotoxicity. Together, these observations suggest that the formation of (·)NO in tumors (associated macrophages) can contribute to VP-16 resistance via the detoxification of VP-16.

摘要

最初被鉴定为一种先天细胞毒素,肿瘤中一氧化氮((·)NO)的形成可以影响化疗并加剧癌症进展。在这里,我们检验了这样一个假设,即(·)NO 的产生有助于癌细胞对广泛使用的抗癌药物依托泊苷(VP-16)产生耐药性。VP-16 的紫外可见光谱在暴露于(·)NO 于水性缓冲液中时没有改变。相比之下,在疏水性介质(氯仿)中,以氧依赖性方式,很容易生成 VP-16 的邻醌和亚硝基-VP-16 的红棕色化合物。当 VP-16 自由基(由 VP-16 和辣根过氧化物酶/H2O2 产生)直接暴露于氯仿中存在氧气的(·)NO 时,也会形成类似的产物。电子自旋共振和紫外可见分析表明 VP-16 反应提取物的分离和光谱分析生成了 VP-16 的苯氧基自由基和邻醌,以及可能的氮氧化物中间体、硝酮、亚硝酮和其他氮氧化物中间体。VP-16 的一氧化氮产物显示出拓扑异构酶 II 依赖性 DNA 切割和对人 HL-60 白血病细胞的细胞毒性显著降低。与 Raw 细胞相比,LPS 介导的鼠巨噬细胞中一氧化氮合酶的诱导导致 VP-16 耐药。此外,iNOS 衍生的(·)NO 产物与 VP-16 迅速反应,导致 DNA 损伤和细胞毒性降低。总之,这些观察结果表明,肿瘤(相关巨噬细胞)中(·)NO 的形成可能通过 VP-16 的解毒作用导致 VP-16 耐药。

相似文献

1
Role of nitric oxide in the chemistry and anticancer activity of etoposide (VP-16,213).一氧化氮在依托泊苷(VP-16,213)的化学性质和抗癌活性中的作用。
Chem Res Toxicol. 2013 Mar 18;26(3):379-87. doi: 10.1021/tx300480q. Epub 2013 Feb 26.
2
Effect of nitric oxide on the anticancer activity of the topoisomerase-active drugs etoposide and adriamycin in human melanoma cells.一氧化氮对拓扑异构酶活性药物依托泊苷和阿霉素在人黑色素瘤细胞中抗癌活性的影响。
J Pharmacol Exp Ther. 2013 Dec;347(3):607-14. doi: 10.1124/jpet.113.207928. Epub 2013 Sep 18.
3
Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells.一氧化氮抑制拓扑异构酶II的活性,并诱导人类肿瘤细胞对拓扑异构酶II抑制剂产生抗性。
Biochim Biophys Acta. 2016 Jul;1860(7):1519-27. doi: 10.1016/j.bbagen.2016.04.009. Epub 2016 Apr 17.
4
Topoisomerase II-mediated DNA cleavage and mutagenesis activated by nitric oxide underlie the inflammation-associated tumorigenesis.一氧化氮介导的拓扑异构酶 II 介导的 DNA 断裂和突变激活是炎症相关肿瘤发生的基础。
Antioxid Redox Signal. 2013 Apr 1;18(10):1129-40. doi: 10.1089/ars.2012.4620. Epub 2012 Nov 23.
5
Nitric oxide trapping of the tyrosyl radical-chemistry and biochemistry.酪氨酸自由基的一氧化氮捕获——化学与生物化学
Toxicology. 2002 Aug 1;177(1):1-9. doi: 10.1016/s0300-483x(02)00191-9.
6
Ascorbate is the primary reductant of the phenoxyl radical of etoposide in the presence of thiols both in cell homogenates and in model systems.在细胞匀浆和模型系统中,在存在硫醇的情况下,抗坏血酸盐是依托泊苷苯氧自由基的主要还原剂。
Biochemistry. 1994 Aug 16;33(32):9651-60. doi: 10.1021/bi00198a034.
7
In vivo etoposide-resistant C6 glioma cell line: significance of altered DNA topoisomerase II activity in multi-drug resistance.体内依托泊苷耐药C6胶质瘤细胞系:DNA拓扑异构酶II活性改变在多药耐药中的意义
J Neurooncol. 1998 Jan;36(1):41-53. doi: 10.1023/a:1005718912236.
8
Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylation.钙调蛋白依赖性过程抑制剂使依托泊苷耐药细胞致敏所涉及的细胞事件。对细胞凋亡、DNA可切割复合物及磷酸化作用的影响。
Biochem Pharmacol. 1996 Dec 24;52(12):1903-9. doi: 10.1016/s0006-2952(96)00692-2.
9
Mechanisms of nitric oxide protection against tert-butyl hydroperoxide-induced cytotoxicity in iNOS-transduced human erythroleukemia cells.一氧化氮对诱导型一氧化氮合酶转导的人红白血病细胞中叔丁基过氧化氢诱导的细胞毒性的保护机制。
Biochemistry. 1999 Aug 17;38(33):10691-8. doi: 10.1021/bi9829229.
10
Tyrosine iminoxyl radical formation from tyrosyl radical/nitric oxide and nitrosotyrosine.由酪氨酸自由基/一氧化氮和亚硝基酪氨酸形成酪氨酸亚胺氧基自由基。
J Biol Chem. 2001 Dec 7;276(49):45516-21. doi: 10.1074/jbc.M106835200. Epub 2001 Sep 10.

引用本文的文献

1
Spin Trapping of Nitric Oxide by Hemoglobin and Ferrous Diethyldithiocarbamate in Model Tumors Differing in Vascularization.在血管化程度不同的模型肿瘤中,血红蛋白和二乙基二硫代氨基甲酸亚铁对一氧化氮的自旋捕获
Int J Mol Sci. 2024 Apr 10;25(8):4172. doi: 10.3390/ijms25084172.
2
Glycyrrhizin as a Nitric Oxide Regulator in Cancer Chemotherapy.甘草酸作为癌症化疗中的一氧化氮调节剂
Cancers (Basel). 2021 Nov 17;13(22):5762. doi: 10.3390/cancers13225762.
3
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer.

本文引用的文献

1
Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.在人类乳腺癌中,诱导型一氧化氮合酶与基底样转录模式和肿瘤进展相关的候选途径。
Cell Cycle. 2011 Feb 15;10(4):619-24. doi: 10.4161/cc.10.4.14864.
2
Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.NOS2 表达增加预示着雌激素受体阴性乳腺癌患者的预后不良。
J Clin Invest. 2010 Nov;120(11):3843-54. doi: 10.1172/JCI42059. Epub 2010 Oct 18.
3
Nitric oxide and cancer therapy: the emperor has NO clothes.
可溶性鸟苷酸环化酶信号转导介导进展期小细胞肺癌对依托泊苷的耐药性。
Nat Commun. 2021 Nov 17;12(1):6652. doi: 10.1038/s41467-021-26823-6.
4
Role of Oxygen and Nitrogen Radicals in the Mechanism of Anticancer Drug Cytotoxicity.氧自由基和氮自由基在抗癌药物细胞毒性机制中的作用
J Cancer Sci Ther. 2020;12(1):10-18. Epub 2020 Jan 24.
5
Nitric oxide: Friend or Foe in Cancer Chemotherapy and Drug Resistance: A Perspective.一氧化氮:癌症化疗与耐药性中的朋友还是敌人?一种观点
J Cancer Sci Ther. 2016;8:244-251. doi: 10.4172/1948-5956.1000421. Epub 2016 Oct 28.
6
Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells.JS-K 及一氧化氮逆转 ABCB1 和 ABCG2 表达的多药耐药人肿瘤细胞的耐药性。
Biomed Pharmacother. 2019 Dec;120:109468. doi: 10.1016/j.biopha.2019.109468. Epub 2019 Oct 9.
7
Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non-Hodgkin lymphoma.采用依维莫司和依托泊苷的节拍式联合化疗治疗非霍奇金淋巴瘤。
Cancer Med. 2019 Aug;8(10):4688-4698. doi: 10.1002/cam4.2364. Epub 2019 Jun 20.
8
Polydopamine Modified Superparamagnetic Iron Oxide Nanoparticles as Multifunctional Nanocarrier for Targeted Prostate Cancer Treatment.聚多巴胺修饰的超顺磁性氧化铁纳米颗粒作为靶向前列腺癌治疗的多功能纳米载体
Nanomaterials (Basel). 2019 Jan 22;9(2):138. doi: 10.3390/nano9020138.
9
Nitric oxide reverses drug resistance by inhibiting ATPase activity of p-glycoprotein in human multi-drug resistant cancer cells.一氧化氮通过抑制人多药耐药癌细胞 P-糖蛋白的 ATP 酶活性逆转耐药性。
Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2806-2814. doi: 10.1016/j.bbagen.2018.08.021. Epub 2018 Sep 1.
10
Nitric oxide inhibits ATPase activity and induces resistance to topoisomerase II-poisons in human MCF-7 breast tumor cells.一氧化氮抑制人MCF-7乳腺癌细胞中的ATP酶活性并诱导对拓扑异构酶II抑制剂的抗性。
Biochem Biophys Rep. 2017 Apr 20;10:252-259. doi: 10.1016/j.bbrep.2017.04.011. eCollection 2017 Jul.
一氧化氮与癌症治疗:皇帝没穿衣服。
Curr Pharm Des. 2010;16(4):381-91. doi: 10.2174/138161210790232149.
4
Site-specific carboxypeptidase B1 tyrosine nitration and pathophysiological implications following its physical association with nitric oxide synthase-3 in experimental sepsis.实验性脓毒症中位点特异性羧肽酶B1与一氧化氮合酶-3发生物理关联后的酪氨酸硝化及其病理生理意义
J Immunol. 2009 Sep 15;183(6):4055-66. doi: 10.4049/jimmunol.0900593. Epub 2009 Aug 28.
5
Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization.肿瘤细胞和巨噬细胞之间的趋化因子信号转导调节癌细胞的迁移、转移和新生血管形成。
PLoS One. 2009 Aug 21;4(8):e6713. doi: 10.1371/journal.pone.0006713.
6
The essential role of Oct-2 in LPS-induced expression of iNOS in RAW 264.7 macrophages and its regulation by trichostatin A.Oct-2在脂多糖诱导RAW 264.7巨噬细胞中诱导型一氧化氮合酶表达中的重要作用及其受曲古抑菌素A的调节
Am J Physiol Cell Physiol. 2009 May;296(5):C1133-9. doi: 10.1152/ajpcell.00031.2009. Epub 2009 Mar 11.
7
Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis.人黑色素瘤中诱导型一氧化氮合酶(iNOS)和一氧化氮(NO)的组成型细胞内产生:在生长调节和抗凋亡中的可能作用。
Nitric Oxide. 2008 Sep;19(2):133-7. doi: 10.1016/j.niox.2008.04.009. Epub 2008 Apr 22.
8
Macrophages define the invasive microenvironment in breast cancer.巨噬细胞决定了乳腺癌的侵袭性微环境。
J Leukoc Biol. 2008 Sep;84(3):623-30. doi: 10.1189/jlb.1107762. Epub 2008 May 8.
9
Plasma membrane cholesterol content affects nitric oxide diffusion dynamics and signaling.质膜胆固醇含量影响一氧化氮的扩散动力学和信号传导。
J Biol Chem. 2008 Jul 4;283(27):18513-21. doi: 10.1074/jbc.M800440200. Epub 2008 Apr 29.
10
Increased inducible nitric oxide synthase in lung carcinoma of smokers.吸烟者肺癌中诱导型一氧化氮合酶增加。
Cancer. 2008 Jan 15;112(2):372-81. doi: 10.1002/cncr.23166.